Violations Of 21 CFR Part 58 - Good Laboratory Practice for Nonclinical Laboratory: Warning Letters Issued by U.S. Food and Drug Administration
cena:451.87 zł |
Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration
cena:588.80 zł |
Violations Of 21 CFR Part 803 - Medical Device Reporting: Warning Letters Issued by U.S. Food and Drug Administration
cena:730.30 zł |
Violations Of 21 CFR Part 806 - Medical Devices; Reports Of Corrections And Removals: Warning Letters Issued by U.S. Food and Drug Administration
cena:451.87 zł |
Violations Of 21 CFR Part 812 - Investigational Device Exemptions: Warning Letters Issued by U.S. Food and Drug Administration
cena:730.30 zł |
Violations Of 21 CFR Part 820 Quality System Regulation, Subparts A-B: General Provisions and Quality System Requirements: Warning Letters Issued by U
cena:588.80 zł |
Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart C Design Controls: Warning Letters Issued by U.S. Food and Drug Administration
cena:680.09 zł |
Violations Of 21 CFR Part 820 Quality System Regulation, Subparts D-F: Document Controls, Purchasing Controls, Identification and Traceability: Warnin
cena:543.15 zł |
Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart G Production and Process Controls: Warning Letters Issued by U.S. Food and Drug Adm
cena:639.01 zł |
Violations Of 21 CFR Part 820 Quality System Regulation, Subparts H-I: Acceptance Activities and Nonconforming Product: Warning Letters Issued by U.S.
cena:680.09 zł |
Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart J Corrective and Preventive Action: Warning Letters Issued by U.S. Food and Drug Ad
cena:730.30 zł |
Violations Of 21 CFR Part 820 Quality System Regulation: Subpart K- Labeling and Packaging Control, Subpart L- Handling, Storage, Distribution, and In
cena:451.87 zł |